Market Place
Sourcing Support
FDA approves Lupin`s Lenalidomide capsules
17 Sep 2025 //
INDPHARMAPOST
Cigna Files Anti-Competition Lawsuit Against BMS Over Pomalyst
25 Jun 2025 //
FIERCE PHARMA
BMS Reports Mixed Earnings as Portfolio due to Generic Pressure
26 Apr 2025 //
BIOSPACE
Kexing Biopharm`s Albumin-bound Paclitaxel Granted EU Market Approval
31 Jul 2024 //
PR NEWSWIRE
Bristol Myers’ leukemia blockbuster set to face generic rivals
13 Jul 2024 //
BIOPHARMADIVE
US FDA mandates label updates on CAR-T cancer therapies
19 Apr 2024 //
REUTERS
Standard Bio Announces Strategic Engagement with BMS for the SomaScan® Platform
03 Apr 2024 //
GLOBENEWSWIRE
BMS, generics companies face new suit over Revlimid `monopoly`
22 Nov 2022 //
FIERCEPHARMA
With latest Keytruda approval, Merck beats Bristol Myers to immunotherapy target
18 Jun 2020 //
BIOPHA RMADIVE
The top 10 all-time biggest-selling drugs by 2024
15 Aug 2019 //
FIERCE PHARMA
FDA Unveils 34 New and Revised Product-Specific Draft Guidances
17 May 2019 //
RAPS
Gilead schemed with J&J, BMS to protect HIV combos: lawsuit
15 May 2019 //
FIERCE PHARMA
Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments
14 May 2019 //
CNBC
Starboard Value has 1M -share stake in Bristol-Myers has met with management
22 Feb 2019 //
CNBC
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms
20 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
01 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
01 Nov 2018 //
PATENT LITIGATION
Fortemet (Metformin Hydrochloride) : Shionogi vs. Amneal Pharmaceuticals
19 Oct 2018 //
PATENT LITIGATION
China answers outcry over cancer drug prices with speedy cuts
10 Jul 2018 //
FIERCE PHARMA
BMS Korea wins fight for Eliquis patent
29 Jun 2018 //
KOREABIOMED
With Generic and Over-the-Counter Viagra Coming, Pfizer Looks for a Viable
02 Apr 2018 //
BIOSPACE
Eliquis® (Apixaban): Bristol-Myers Squibb Company V. Dr. Reddy`s Laboratories
19 Jan 2018 //
PATENT LITIGATION
Rising Pharmaceuticals launches generic Sustiva
04 Jan 2018 //
DRUG STORE NEWS
U.K. pulls manufacturing authorization from Bristol Laboratories
29 Aug 2017 //
FIERCE PHARMA
Opdivo° (Nivolumab): Bristol-Myers Squibb V. Emd Serono & Merck Kgaa
26 Jul 2017 //
PATENT LITIGATION
Imfinzi (Durvalumab): Bristol-Myers Squib V. Astrazeneca, E. R. Squibb & Sons Ono Tasuku Honjo
26 Jul 2017 //
PATENT LITIGATION
Tecentriq (Atezolizumab): Bristol-Myers Squibb Co. Et Al V.Genentech,
26 Jul 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Prinston Pharmaceutical
13 Apr 2017 //
PATENT LITIGATION
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
13 Apr 2017 //
FIERCE PHARMA
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Mylan Pharmaceuticals
12 Apr 2017 //
PATENT LITIGATION
Bristol-Myers, Pfizer Sue To Halt Generic Blood Thinner
12 Apr 2017 //
LAW
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Zydus Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Micro Labs
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Wockhardt
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Accord Healthcare
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Macleods Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Apotex
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Impax Laboratories
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sandoz
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sigmapharm Laboratories
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Dr. Reddy’s Laboratories
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sun Pharmaceutical Industries
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Teva Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Indoco Remedies
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Emcure Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Unichem Laboratories
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Lupin
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Hetero Labs
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sunshine Lake Pharma & HEC Pharm
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Torrent Pharmaceuticals
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Breckenridge Pharmaceutical
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. InvaGen Pharmaceuticals
05 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Aurobindo Pharma
05 Apr 2017 //
PATENT LITIGATION
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
Cipla gets US FDA approval for generic Baraclude tablets
08 Dec 2016 //
PHARMABIZ
Two Indian generics makers end battle to copy drugs amid patent debate
13 Apr 2016 //
REUTERS
Desi generics firms pave way for cheaper hepatitis C drug
18 Jan 2016 //
ECONOMIC TIMES
Otsuka faces the music for generic Abilify, loses battle with FDA
30 May 2015 //
FIERCE PHARMA
FDA approves generic versions of antipsychotic drug Abilify
29 Apr 2015 //
REUTERS
